Nooij, SamDucarmon, Quinten RLaros, Jeroen F JZwittink, Romy DNorman, Jason MSmits, Wiep KlaasVerspaget, Hein WKeller, Josbert JTerveer, Elisabeth MKuijper, Ed J2021-07-122021-07-122021-06-113412606210.1053/j.gastro.2021.06.009http://hdl.handle.net/10029/625067Patients with multiple recurrent Clostridioides difficile infection (rCDI) have a disturbed gut microbiota that can be restored by fecal microbiota transplantation (FMT). Despite extensive screening, healthy feces donors may carry bacteria in their intestinal tract that could have long-term health effects, such as potentially procarcinogenic polyketide synthase-positive (pks+) Escherichia coli. Here, we aim to determine whether the pks abundance and persistence of pks+E coli is influenced by pks status of the donor feces.enCopyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.ColibactinColorectal CancerGenotoxinMicrobiomeFecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients.Article1528-0012Gastroenterology 2021; 161(4):1218-28